EU medicines regulator says benefits of J&J vaccine outweigh risks as it reviews rare blood clots

Europe's medicines regulator on Wednesday said it still believes the benefits of Johnson & Johnson's Covid-19 vaccine outweigh the risks of side effects.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.